share_log

B. Riley Securities Initiates Coverage On Gritstone Bio With Buy Rating, Announces Price Target of $8

B. Riley Securities Initiates Coverage On Gritstone Bio With Buy Rating, Announces Price Target of $8

萊利證券以買入評級啟動對格利斯通生物的覆蓋率,宣布目標價格為 8 美元
Benzinga ·  2023/03/28 05:23

B. Riley Securities analyst Mayank Mamtani initiates coverage on Gritstone Bio (NASDAQ:GRTS) with a Buy rating and announces Price Target of $8.

萊利證券分析師瑪雅銀行 Mayank Mamtani 以「買入」評級啟動了格利斯通生物(NASDAQ:GRTS)的報導,並宣布目標價為 8 美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論